FASN and neurodegenerative disease: Additionally, obese mice administered with orlistat showed functional shifts in the gut microbiota, with gene enrichment in pathways related to “cell motility” and “Neurodegenerative Diseases.” These changes may be linked to orlistat’s effect on fatty acid synthase levels, crucial for orlistat’s positive outcomes (44).